Naoya Sakamoto
Papers
1
Total Citations
88
H-Index
1
About
Naoya Sakamoto is a leading virologist whose research focuses on hepatitis C virus (HCV) replication and the development of antiviral strategies. His most cited work, a 2006 study published in *Gastroenterology*, introduced a cell-based, high-throughput screening platform to identify small molecule regulators of HCV replication. This pioneering approach, which has garnered 88 citations, enabled the rapid discovery of compounds that inhibit viral RNA replication, laying critical groundwork for the development of direct-acting antiviral therapies that have since transformed HCV treatment. Sakamoto’s contributions extend beyond methodology; his work has deepened understanding of host-virus interactions and drug resistance mechanisms. By bridging basic virology with translational drug discovery, he has significantly impacted the field, offering new avenues for combating chronic hepatitis C. His research remains highly influential among scientists studying viral replication and antiviral drug development.
Research Focus
Key Achievements
Top Papers
- 1